Robert J. Fontana
Impact in
- Hepatology top 0.01%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Pharmacology top 0.01%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
- Hepatology 213
- Liver Disease and Transplantation 118
- Hepatitis C virus research 113
- Epidemiology 177
- Liver Disease Diagnosis and Treatment 147
- Hepatitis B Virus Studies 63
- Co-authors
- Anna S. Lok (54 shared papers)Jorge A. Marrero (17 shared papers)Hari S. Conjeevaram (14 shared papers)William M. Lee (57 shared papers)Timothy J. Davern (31 shared papers)Chun‐Tao Wai (4 shared papers)Joel K. Greenson (5 shared papers)John D. Kalbfleisch (1 shared paper)
- Journals
- Hepatology (54 papers)The American Journal of Gastroenterology (30 papers)Gastroenterology (26 papers)Liver Transplantation (22 papers)Digestive Diseases and Sciences (21 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert J. Fontana
356 papers receiving 26.9k citations
Robert J. Fontana's Hit Papers
Peers
Comparison fields: 5 of 187
- Hepatology 15.0k
- Pharmacology 9.3k
- Epidemiology 14.3k
- Emergency Medicine 1.3k
- Transplantation 324
Countries citing papers authored by Robert J. Fontana
This map shows the geographic impact of Robert J. Fontana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Fontana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Fontana more than expected).
Fields of papers citing papers by Robert J. Fontana
This network shows the impact of papers produced by Robert J. Fontana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Fontana. The network helps show where Robert J. Fontana may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert J. Fontana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 376 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C Hit paper breakdown → | 2003 | 3426 |
| 2 | Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States Hit paper breakdown → | 2002 | 1570 |
| 3 | Acetaminophen‐induced acute liver failure Hit paper breakdown → | 2005 | 1441 |
| 4 | ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury Hit paper breakdown → | 2014 | 641 |
| 5 | Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States Hit paper breakdown → | 2008 | 638 |
| 6 | Recent System Applications of Short-Pulse Ultra-Wideband (UWB) Technology Hit paper breakdown → | 2004 | 533 |
| 7 | 1997 | 495 | |
| 8 | 2005 | 466 | |
| 9 | Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure Hit paper breakdown → | 2009 | 431 |
| 10 | 2009 | 368 | |
| 11 | 2004 | 356 | |
| 12 | Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement Hit paper breakdown → | 2020 | 338 |
| 13 | 2010 | 337 | |
| 14 | Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence Hit paper breakdown → | 2016 | 331 |
| 15 | 2003 | 308 | |
| 16 | 2002 | 303 | |
| 17 | 2013 | 298 | |
| 18 | Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network Hit paper breakdown → | 2014 | 292 |
| 19 | 2007 | 261 | |
| 20 | 2005 | 258 |
About Robert J. Fontana
Robert J. Fontana is a scholar working on Hepatology, Epidemiology, Pharmacology, Oncology and Surgery, having authored 376 papers that have together received 27.7k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (149 papers), Liver Disease Diagnosis and Treatment (147 papers), Liver Disease and Transplantation (118 papers), Hepatitis C virus research (113 papers), Hepatitis B Virus Studies (63 papers), Pharmacogenetics and Drug Metabolism (59 papers), Drug Transport and Resistance Mechanisms (33 papers) and Poisoning and overdose treatments (24 papers). The work is most often cited by research in Hepatology (15.0k citations), Pharmacology (9.3k citations), Epidemiology (14.3k citations), Emergency Medicine (1.3k citations) and Transplantation (324 citations). Robert J. Fontana has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Anna S. Lok, Jorge A. Marrero, Hari S. Conjeevaram, William M. Lee, Timothy J. Davern, Chun‐Tao Wai, Joel K. Greenson, John D. Kalbfleisch, Herbert L. Bonkovsky and Naga Chalasani. Their work appears in journals such as Hepatology, The American Journal of Gastroenterology, Gastroenterology, Liver Transplantation and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.